This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Humana Extends Contract With Tivity Health, Spurs Healthcare
by Zacks Equity Research
Humana (HUM) continues to form strategic partnerships to improve the overall health of its Medicare Advantage members.
Top Research Reports for Microsoft, Intel & UnitedHealth
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Intel (INTC) and UnitedHealth (UNH).
Tenet Healthcare Grows on Acquisitions, Lower Revenues Hurt
by Zacks Equity Research
Tenet Healthcare (THC) gains from buyouts, divestitures and strategic initiatives. However, fall in revenues and high level of debt continue to bother.
UnitedHealth (UNH) Arm to Buy Chilean Company for $2.8B
by Zacks Equity Research
UnitedHealth (UNH) is set to buy Empresas Banmedica in order to expand its international operations.
Anthem Buys HealthSun to Expand Medicare Business in Florida
by Zacks Equity Research
Anthem's (ANTM) buyout of HealthSun reflects its long-term strategy to grow in the Medicare Advantage business.
Can CVS Health Recover From the Shocks of 2016 & 17?
by Zacks Equity Research
CVS Health (CVS) looks for ways to return to growth.
Humana-Kindred Deal Keeps Shakeout Alive in Healthcare Space
by Zacks Equity Research
Humana's (HUM) agreement to acquire Kindred at Home aligns with its strategy to grow vertically.
WellCare Health (WCG) 2018 Guidance: What's in the Cards?
by Zacks Equity Research
Wellcare Health's (WCG) strong 2018 guidance instills investors' confidence in the company.
CVS-Aetna Deal Leading a Wave of Change in Hospital Sector
by Zacks Equity Research
Increased consolidation is being witnessed in the hospital sector as a defense against invasion by new comers.
Discount Retail Stocks, LULU Earnings, & Healthcare Consolidation
by Ryan McQueeney
On today's episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week's biggest stories, including the latest earnings results from Dollar General (DG) and Lululemon (LULU), as well as major healthcare M&A deals involving CVS (CVS), Aetna (AET), and UnitedHealth (UNH).
UnitedHealth on A.M.Best's Radar After Buyout Announcement
by Zacks Equity Research
A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.
Company News For Dec 7, 2017
by Zacks Equity Research
Companies In The News are: PLAY,OXM,HRB,DVA,UNH
UnitedHealth to Buy DaVita Medical, Expands Optum Business
by Zacks Equity Research
UnitedHealth's (UNH) intention to buy DaVita Medical reflects its continuous effort to build up a vertically integrated business model
UnitedHealth Continues Healthcare Shakeup With DaVita Deal
by Benjamin Rains
On Wednesday, only a few days after the CVS (CVS) and Aetna (AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (UNH) announced that it will buy a unit of DaVita Inc. (DVA) for nearly $5 billion.
Aetna, CVS Health Ink a Merger Agreement Worth $69 Billion
by Zacks Equity Research
Aetna's (AET) acquisition by CVS Health promises to expand the former's scale and size, and improve its access to health at lower cost.
Will Aetna Be Acquired by CVS Health to Rest Speculations?
by Zacks Equity Research
Aetna's (AET) likely acquisition by CVS Health promises to improve the company's scale and size, thus allowing it to better negotiate over drug prices.
UnitedHealth Keeps '17 Guidance & Issues '18 View, Stock Up
by Zacks Equity Research
UnitedHealth's (UNH) strong guidance for 2018 reflects its robust fundamentals amid a volatile regulatory backdrop.
Company News For Nov 28, 2017
by Zacks Equity Research
Companies in the news are: TIME,CUDA,TECD,UNH,MDP
Humana's Medicare Business Impresses, Public Exchange Hurts
by Zacks Equity Research
Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.
Can Health Insurers Continue to Look Past ACA Threats in Q4?
by Zacks Equity Research
Despite regulatory challenges, health insurance companies have the potential to outperform in Q4 on growing demand for government plans, reduced uninsured rates and aging U.S. population.
Anthem (ANTM) Grows on Membership, Rising Expenses Hurt
by Zacks Equity Research
Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.
UnitedHealth (UNH) Up 3.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss
by Zacks Equity Research
Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.
Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.